Femasys Inc. (NASDAQ:FEMY) Sees Large Increase in Short Interest

Femasys Inc. (NASDAQ:FEMY) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,150,000 shares, an increase of 74.5% from the February 28th total of 658,900 shares. Based on an average daily volume of 391,100 shares, the days-to-cover ratio is presently 2.9 days. Approximately 5.9% of the company’s shares are short sold.

Femasys Stock Down 3.4 %

Shares of NASDAQ:FEMY traded down $0.05 on Friday, reaching $1.29. The company had a trading volume of 213,847 shares, compared to its average volume of 244,761. The firm has a market capitalization of $29.54 million, a PE ratio of -1.59 and a beta of -2.85. The company has a current ratio of 3.94, a quick ratio of 3.26 and a debt-to-equity ratio of 0.86. Femasys has a 52-week low of $0.86 and a 52-week high of $1.84. The firm’s 50 day simple moving average is $1.41 and its 200-day simple moving average is $1.23.

Femasys (NASDAQ:FEMY) last posted its earnings results on Thursday, March 27th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.25) by $0.02. Femasys had a negative return on equity of 141.49% and a negative net margin of 1,435.77%. The company had revenue of $0.58 million for the quarter, compared to analyst estimates of $1.66 million. As a group, analysts expect that Femasys will post -0.86 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Femasys

Several institutional investors have recently bought and sold shares of the company. Citadel Advisors LLC purchased a new stake in Femasys in the fourth quarter valued at about $45,000. Northern Trust Corp raised its stake in Femasys by 42.6% in the 4th quarter. Northern Trust Corp now owns 126,096 shares of the company’s stock worth $139,000 after acquiring an additional 37,675 shares during the last quarter. Jane Street Group LLC purchased a new position in Femasys in the 4th quarter worth $30,000. Virtu Financial LLC purchased a new stake in Femasys during the 4th quarter valued at about $25,000. Finally, XTX Topco Ltd increased its holdings in shares of Femasys by 123.9% in the third quarter. XTX Topco Ltd now owns 32,535 shares of the company’s stock valued at $36,000 after purchasing an additional 18,004 shares during the period. 65.27% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and set a $15.00 target price on shares of Femasys in a research report on Friday.

Femasys Company Profile

Femasys Inc, a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination.